US Acute Intermittent Porphyria Market Gains Momentum in Diagnostics
The US acute intermittent porphyria market is expanding due to increasing awareness of this rare genetic disorder and improved diagnosis of porphyria-related symptoms. Growing availability of specialized therapies, advancements in disease management, and rising focus on rare-disease treatment are supporting market development. Increased research and development activities are also encouraging...
0 Comments
0 Shares